Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/apt.12046PMID 22966992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese

  2012cited by this paper
• The epidemiology, pathogenesis and histopathology of fatty liver disease

  2012influential reference
• Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.

  2012cited by this paper
• Hedgehog signaling.

  2012cited by this paper
• Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review.

  2012cited by this paper
• Hedgehog signaling.

  2012cited by this paper
• Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle

  2012cited by this paper
• Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

  2012cited by this paper
• Mechanisms of disease progression in NASH: new paradigms.

  2012cited by this paper
• Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease

  2012cited by this paper
• Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease

  2012cited by this paper
• NAFLD in the Absence of Metabolic Syndrome: Different Epidemiology, Pathogenetic Mechanisms, Risk Factors for Disease Progression?

  2012cited by this paper
• NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

  2012cited by this paper
• Can NASH be diagnosed, graded, and staged noninvasively?

  2012cited by this paper
• Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research

  2012cited by this paper
• Apoptosis: why and how does it occur in biology?

  2011cited by this paper
• The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population

  2011cited by this paper
• Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease.

  2011influential reference
• Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.

  2011cited by this paper
• Systematic review of performance of non‐invasive biomarkers in the evaluation of non‐alcoholic fatty liver disease

  2011cited by this paper
• 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.

  2011cited by this paper
• Genetic variants in candidate genes influencing NAFLD progression

  2011cited by this paper
• Upregulation of Hemoglobin Expression by Oxidative Stress in Hepatocytes and Its Implication in Nonalcoholic Steatohepatitis

  2011cited by this paper
• Mechanisms of Lipotoxicity in NAFLD and Clinical Implications

  2011cited by this paper
• Genetics of alcoholic and nonalcoholic fatty liver disease.

  2011cited by this paper
• Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy.

  2011cited by this paper
• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

  2011cited by this paper
• Non-alcoholic fatty liver disease: what's new under the microscope?

  2011cited by this paper
• Steatotic liver: a suitable source for the isolation of hepatic progenitor cells

  2011cited by this paper
• Increased production of sonic hedgehog by ballooned hepatocytes

  2011cited by this paper
• Non-alcoholic fatty liver disease: a massive problem.

  2011cited by this paper
• Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis

  2011cited by this paper
• Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies?

  2011cited by this paper
• Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

  2011cited by this paper
• Endpoints and clinical trial design for nonalcoholic steatohepatitis

  2011influential reference
• Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

  2011cited by this paper
• Non-Alcoholic Steatohepatitis Pathogenesis: Role of Repair in Regulating the Disease Progression

  2010cited by this paper
• High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double‐blind, randomized, placebo‐controlled trial

  2010cited by this paper
• Association of polymorphisms of glutamate‐cystein ligase and microsomal triglyceride transfer protein genes in non‐alcoholic fatty liver disease

  2010cited by this paper
• Roles of liver innate immune cells in nonalcoholic fatty liver disease.

  2010cited by this paper
• Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

  2010cited by this paper
• Nonalcoholic steatohepatitis: risk factors and diagnosis

  2010cited by this paper
• Liver Biopsy for Histological Assessment – The Case Against

  2010influential reference
• Nonalcoholic fatty liver disease.

  2010cited by this paper
• A meta‐analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

  2010cited by this paper
• Histopathology of nonalcoholic fatty liver disease.

  2010cited by this paper
• Non-invasive diagnostic tests for non-alcoholic fatty liver disease.

  2010cited by this paper
• The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.

  2010cited by this paper
• Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

  2010cited by this paper
• The association of genetic variability in patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

  2010cited by this paper
• Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

  2010influential reference
• Nonalcoholic fatty liver disease.

  2010cited by this paper
• Hepatic progenitor cells: an update.

  2010cited by this paper
• Non-alcoholic steatohepatitis with normal aminotransferase values.

  2009cited by this paper
• A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

  2009cited by this paper
• Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease.

  2009cited by this paper
• Stem/progenitor cells in liver injury repair and regeneration

  2009cited by this paper
• A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity

  2009cited by this paper
• Systematic review: caspase‐cleaved fragments of cytokeratin 18 – the promises and challenges of a biomarker for chronic liver disease

  2009cited by this paper
• Noninvasive assessment of fibrosis and steatosis in NASH and ASH.

  2009cited by this paper
• Serum M30 levels: A potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels

  2009cited by this paper
• Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.

  2009cited by this paper
• Review article: diagnosis and treatment of non‐alcoholic fatty liver disease

  2008cited by this paper
• Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

  2008cited by this paper
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

  2008cited by this paper
• Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis

  2008cited by this paper
• A Novel Role for Hedgehog in T-Cell Receptor Signaling: Implications for Development and Immunity

  2007cited by this paper
• Sonic hedgehog signalling in T-cell development and activation

  2007cited by this paper
• GI Epidemiology: nonalcoholic fatty liver disease

  2007cited by this paper
• The role of cytokines in non-alcoholic steatohepatitis. A review.

  2006cited by this paper
• Review article: drug therapy for non‐alcoholic fatty liver disease

  2006cited by this paper
• Adiponutrin gene is regulated by insulin and glucose in human adipose tissue.

  2006cited by this paper
• Non-alcoholic steatohepatitis: from cell biology to clinical practice.

  2006cited by this paper
• Variation in the adiponutrin gene influences its expression and associates with obesity.

  2006cited by this paper
• The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

  2005cited by this paper
• Review article: the treatment of non‐alcoholic steatohepatitis with thiazolidinediones

  2005cited by this paper
• Review article: role of oxidative stress in the progression of non‐alcoholic steatosis

  2005cited by this paper
• Increased risk of NASH in patients carrying the C(−159)T polymorphism in the CD14 gene promoter region

  2005cited by this paper
• Review article: hepatic steatosis and insulin resistance

  2005cited by this paper
• The wide spectrum of steatohepatitis: a report of four cases and a review of the literature

  2004cited by this paper
• The Notch and Sonic hedgehog signalling pathways in immunity.

  2004cited by this paper
• The histologic spectrum of nonalcoholic fatty liver disease.

  2004cited by this paper
• The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

  2003cited by this paper
• Nonalcoholic fatty liver disease (NAFLD) two decades later: are we smarter about its natural history?

  2003cited by this paper
• Non-alcoholic fatty liver disease: an emerging pathological spectrum

  2003cited by this paper
• Hepatic progenitor cells in human liver diseases.

  2002cited by this paper
• The Clinicopathologic Spectrum and Management of Nonalcoholic Fatty Liver Disease

  2002cited by this paper
• Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

  2001cited by this paper
• Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds.

  2000cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper

• A Study on The Proportion/Hospital Based Prevalance of Non-Alcoholic Fatty Liver Disease (NAFLD) in Diagnosed Cases of Polycystic Ovarian Syndrome (PCOS) Seen in A Tertiary Care Centre of Bihar

  2025cites this paper
• Quantitative Characterization of Drug Metabolism and Transport Alterations in Obesity with Metabolic Fatty Liver Disease: A Physiologically Based Pharmacokinetic Modelling Approach: Drug Metabolism and Transport in MAFLD: A PBPK Modelling Approach.

  2025cites this paper
• AISI and MASLD: a nonlinear association in U.S. adults (NHANES 2017-2020)

  2025cites this paper
• Metabolic Impact of Alcohol Consumption in MASLD: Understanding MetALD and Beyond.

  2025cites this paper
• Peroxynitrite is key to Cylindrospermopsin-mediated MASLD to MASH progression via triggering TXNIP binding to NLRP3 and subsequent inflammasome activation.

  2025cites this paper
• Unraveling the Gut–Liver–Brain Axis: Microbiome, Inflammation, and Emerging Therapeutic Approaches

  2025cites this paper
• Mechanism of PANoptosis in Metabolic Dysfunction-associated Steatotic Liver Disease.

  2024cites this paper
• A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway.

  2024cites this paper
• Vinpocetine and Lactobacillus improve fatty liver in rats: role of adiponectin and gut microbiome

  2024cites this paper
• Experimental Data on the Role of Melatonin in the Pathogenesis of Nonalcoholic Fatty Liver Disease

  2023cites this paper
• A Decrease in the Activity of Inflammatory and Fibrogenic Pathways in Non-alcoholic Fatty Liver Disease as a Potential Defensive Strategy: A Mini-review

  2023cites this paper
• Apelin and the gut microbiome: Potential interaction in human MASLD.

  2023cites this paper
• Vinpocetine and Lactobacillus improve fatty liver in rats via modulating the oxidative stress, inflammation, adiponectin and gut microbiome.

  2023cites this paper
• Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link

  2023cites this paper
• Association between perfluoroalkyl substances exposure and the prevalence of nonalcoholic fatty liver disease in the different sexes: a study from the National Health and Nutrition Examination Survey 2005–2018

  2023cites this paper
• 1,25-Dihydroxycholecalciferol down-regulates 3-mercaptopyruvate sulfur transferase and caspase-3 in rat model of non-alcoholic fatty liver disease

  2023influential citation
• Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis

  2023cites this paper
• Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets

  2023cites this paper
• Novel approach using [18F]FTHA-PET and de novo synthesized VLDL for assessment of FFA metabolism in a rat model of diet induced NAFLD.

  2023cites this paper
• Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation

  2023cites this paper
• The Role of Oxidative Inactivation of Phosphatase PTEN and TCPTP in Fatty Liver Disease

  2023cites this paper
• The heated debate over NAFLD renaming: An ongoing saga

  2023cites this paper
• Garlic supplementation for the treatment of chronic liver disease: a meta-analysis of randomized controlled trials

  2023cites this paper
• Exercise Training and Probiotic Lacticaseibacillus rhamnosus GG Reduce Tetracycline-Induced Liver Oxidative Stress and Inflammation in Rats with Hepatic Steatosis

  2022cites this paper
• Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease

  2022cites this paper
• Periodontal Disease and Nonalcoholic Fatty Liver Disease: New Microbiome-Targeted Therapy Based on the Oral–Gut–Liver Axis Concept

  2022cites this paper
• Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies

  2022cites this paper
• A Physiologically Based Pharmacokinetic Model to Predict the Impact of Metabolic Changes Associated with Metabolic Associated Fatty Liver Disease on Drug Exposure

  2022cites this paper
• Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS)

  2022cites this paper
• Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male

  2022cites this paper
• The contribution of sterile inflammation to the fatty liver disease and the potential therapies.

  2022cites this paper
• Evaluation of Toxicant-Associated Fatty Liver Disease and Liver Neoplastic Progress in Sprague-Dawley Rats Treated with Low Doses of Aflatoxin B1 Alone or in Combination with Extremely Low Frequency Electromagnetic Fields

  2022cites this paper
• Oyster (Crassostrea gigas) Polysaccharide Ameliorates High-Fat-Diet-Induced Oxidative Stress and Inflammation in the Liver via the Bile Acid-FXR-AMPKα Pathway.

  2022cites this paper
• Tilapia-Head Chondroitin Sulfate Protects against Nonalcoholic Fatty Liver Disease via Modulating the Gut–Liver Axis in High-Fat-Diet-Fed C57BL/6 Mice

  2022cites this paper
• Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention

  2022cites this paper
• Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?

  2022cites this paper
• What's New in Hepatic Steatosis.

  2021cites this paper
• Joint Effect of Hepatic Steatosis and Alanine Aminotransferase Within the Normal Range on Incident Ischemic Heart Disease: A Prospective Study in Koreans

  2021cites this paper
• Protective Effect of Gallic Acid against Nonalcoholic Fatty Liver Disease Induced by High Fat Diet

  2021cites this paper
• Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?

  2021cites this paper
• The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic review

  2021cites this paper
• Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• Role of Nutrient and Energy Sensors in the Development of Type 2 Diabetes

  2021cites this paper
• The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.

  2021cites this paper
• Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial

  2021cites this paper
• Waist-to-height ratio and non-alcoholic fatty liver disease in adults

  2021cites this paper
• Joint Effect of Hepatic Steatosis and Alanine Aminotransferase Within the Normal Range on Incident Ischemic Heart Disease: A Prospective Study in Koreans

  2021cites this paper
• World Journal of Diabetes and

  2021cites this paper
• Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis

  2021cites this paper
• Alleviating effects of noni fruit polysaccharide on hepatic oxidative stress and inflammation in rats under a high-fat diet and its possible mechanisms.

  2020cites this paper
• Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial

  2020cites this paper
• Citrus reticulata Blanco peel extract ameliorates hepatic steatosis, oxidative stress and inflammation in HF and MCD diet-induced NASH C57BL/6 J mice.

  2020cites this paper
• The metabolic basis of nonalcoholic steatohepatitis

  2020cites this paper
• Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management

  2020cites this paper
• Non-alcoholic Fatty Liver Disease: A Global Public Health Issue

  2020cites this paper
• The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases

  2020cites this paper
• Challenges and opportunities in drug development for nonalcoholic steatohepatitis.

  2020cites this paper
• Electron microscopic observations in perfusion-fixed human non-alcoholic fatty liver disease biopsies.

  2020cites this paper
• Lifestyle Modifications Can Suppress Non-Communicable Diseasesin the Iranian Men Elderly

  2020cites this paper
• Role of potato protein hydrolysate and exercise in preventing high-fat diet-induced hepatocyte apoptosis in senescence-accelerated mouse.

  2020cites this paper
• Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence

  2020cites this paper
• Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators.

  2020cites this paper
• Sodium Propionate and Sodium Butyrate Promote Fatty Acid Oxidation in HepG2 Cells under Oxidative Stress

  2020cites this paper
• Bisphenol-A exposure worsens hepatic steatosis in ovariectomized mice fed on a high-fat diet: Role of endoplasmic reticulum stress and fibrogenic pathways.

  2020cites this paper
• Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research

  2020cites this paper
• Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial

  2020cites this paper
• Non‐alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver – a human galactose positron emission tomography study

  2019cites this paper
• Downregulation of hedgehog ligands in human simple steatosis may protect against nonalcoholic steatohepatitis: Is TAZ a crucial regulator?

  2019cites this paper
• ASSOCIATION OF ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS WITH NONALCOHOLIC FATTY LVER DISEASE

  2019cites this paper
• The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease

  2019cites this paper
• From “two hit theory” to “multiple hit theory”: Implications of evolution of pathogenesis concepts for treatment of non-alcoholic fatty liver disease

  2019cites this paper
• Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease

  2019cites this paper
• Steatosis and steatohepatitis found in adults after death due to non-burn trauma

  2019cites this paper
• Tamarind: A diet‐based strategy against lifestyle maladies

  2019cites this paper
• Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis

  2019cites this paper
• Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance.

  2019cites this paper
• Genome-wide analysis of DNA methylation identifies novel differentially methylated regions associated with lipid accumulation improved by ethanol extracts of Allium tubersosum and Capsella bursa-pastoris in a cell model

  2019cites this paper
• A narrative review of factors associated with the development and progression of non‐alcoholic fatty liver disease

  2019cites this paper
• Hepato-protective effects of Glossogyne tenuifolia in Streptozotocin-nicotinamide-induced diabetic rats on high fat diet

  2019cites this paper
• Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice

  2018cites this paper
• UTJECAJ SASTAVA I UDJELA MASNIH KISELINA NA ODLAGANJE LIPIDA I REGULACIJU OTPUŠTANJA GLUKOZE IZ JETRE U ŠTAKORA NA VISOKOMASNOJ PREHRANI

  2018cites this paper
• University of Birmingham Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice

  2018cites this paper
• Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease

  2018cites this paper
• Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta‐analysis

  2018cites this paper
• PPARγ alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2/STAT3 pathway.

  2018cites this paper
• A long‐acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non‐alcoholic steatohepatitis partly through an FGF21‐adiponectin‐IL17A pathway

  2018cites this paper
• Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway

  2018cites this paper
• Papel de pas quinasa en la adaptación a diferentes estados nutricionales y en la resistencia a la obesidad

  2018influential citation
• Progress and challenges in the prevention and control of nonalcoholic fatty liver disease

  2018cites this paper
• PMFs-rich Citrus extract prevents the development of non-alcoholic fatty liver disease in C57BL/6J mice induced by a high-fat diet

  2018cites this paper
• Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis

  2018cites this paper
• LXRɑ participates in the mTOR/S6K1/SREBP-1c signaling pathway during sodium palmitate-induced lipogenesis in HepG2 cells

  2018cites this paper
• The Beneficial Effects of Sitagliptin, a Dipeptedyl Peptidase-4 (DPP-4) Inhibitor on Experimentally Induced Non-Alcoholic Fatty Liver Disease in Rats

  2018cites this paper
• The role of pentraxine-3 and the new non-invasive methods in the diagnostics of non-alcoholic steatohepatitis

  2018cites this paper
• Underlying metabolic processes behind non-alcoholic fatty liver disease in population with metabolic syndrome features: Nutritional status and non-invasive liver tools

  2018cites this paper
• Epidemiology and Comorbidities

  2018cites this paper
• Signaling in Simple Steatosis and Non-alcoholic Steatohepatitis Cirrhosis: TGF-β1, YAP/TAZ, and Hedgehog Pathway Activity

  2018cites this paper
• Non-alcoholic Fatty Liver Disease: What We Learn from Omics Studies

  2018cites this paper
• Activation of the CXCL16/CXCR6 pathway promotes lipid deposition in fatty livers of apolipoprotein E knockout mice and HepG2 cells.

  2018cites this paper
• Exendin‐4, a glucagon‐like peptide‐1 receptor agonist, reduces hepatic steatosis and endoplasmic reticulum stress by inducing nuclear factor erythroid‐derived 2‐related factor 2 nuclear translocation

  2018cites this paper